Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Huntington's disease | R-HSA-1643685 | 0 | digoxigenin | 4826 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | digoxigenin | 4826 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | digoxigenin | 4826 | drug-path |
| Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | digoxigenin | 4826 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | digoxigenin | 4826 | drug-path |
| Cardiac muscle contraction | R-HSA-397014 | map04260 | digoxigenin | 4826 | drug-path |
| Vascular smooth muscle contraction | R-HSA-445355 | map04270 | digoxigenin | 4826 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | digoxigenin | 4826 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | digoxigenin | 4826 | drug-path |
| Homologous recombination | R-HSA-5685942 | map03440 | digoxigenin | 4826 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | digoxigenin | 4826 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | digoxigenin | 4826 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | digoxigenin | 4826 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | digoxigenin | 4826 | drug-path |
| Leukocyte transendothelial migration | R-HSA-8950732 | map04670 | digoxigenin | 4826 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | digoxigenin | 4826 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | digoxigenin | 4826 | drug-path |
| Tight junction | R-HSA-2134514 | map04530 | digoxigenin | 4826 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | digoxigenin | 4826 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | digoxigenin | 4826 | drug-path |